ClinicalTrialsFinder
RecruitingNot ApplicableNCT02445885

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Sponsor

Thomas Engstrom

Enrollment

150 participants

Start Date

May 1, 2015

Study Type

INTERVENTIONAL

Conditions

Ischemic Heart DiseaseST Segment Elevation Myocardial Infarction

Summary

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation. This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients more than 18 years of age.
  • STEMI > 12 hours and < 36 hours.
  • Clinical stable, i.e. no on going angina, hemodynamically stable (systolic BP > 90) and Killip class < 3.

Exclusion Criteria10

  • Clinical instability which requires an acute invasive strategy.
  • Left main occlusion or multivessel disease which requires CABG.
  • Previous Q-wave infarction in the current infarct related artery.
  • Left Bundle Branch Block (LBBB).
  • Severe renal insufficiency.
  • Pacemaker
  • Chronic atrial fibrillation.
  • Previous Coronary Artery Bypass Surgery (CABG).
  • Pregnancy.
  • Other severe illness with life expectancy less than 1 year

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPCI

Guideline directed Percutaneous Coronary Intervention

Locations(1)

Rigshospitalet

Copenhagen, Capital Region, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02445885

Related Trials

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

NCT0709168214 locations

QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial

NCT076354071 location

LONG NAGOMI™ PMCF STUDY

NCT073990027 locations

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT0686315512 locations

Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG

NCT071922111 location